Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study — J Sebastian Miranda Maravi (2024) | RDL Network
Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study
Atherosclerosis 395: 117587-117587
Article 2024 English
Authors
JM
J Sebastian Miranda Maravi
EL
Eric C. Leszczynski
CS
Charles S Schwartz
Abstract
1 min read
Background and aims
Previous studies have derived and validated an HDL apolipoproteomic score (pCAD) that predicts coronary artery disease (CAD) risk. However, the associations between pCAD and markers of cardiometabolic health in healthy adults are not known, nor are the effects of regular exercise on pCAD.
Methods
A total of 641 physically inactive adults free of cardiovascular disease from the HERITAGE Family Study completed 20 weeks of exercise training. The pCAD index (range 0–100) was calculated using measurements of apolipoproteins A-I, C–I, C-II, C-III, and C-IV from ApoA-I-tagged serum (higher index = higher CAD risk). The associations between pCAD index and cardiometabolic traits at baseline and their training responses were assessed with Spearman correlation and general linear models. A Bonferroni correction of p < 8.9 × 10−04 was used to determine statistical significance.
Results
The mean ± SD baseline pCAD index was 29 ± 32, with 106 (16.5 %) participants classified as high CAD risk. At baseline, pCAD index was positively associated with blood pressure, systemic inflammation, and body composition. HDL size, VO2max, and HDL-C were negatively associated with pCAD index at baseline. Of those classified as high CAD risk at baseline, 52 (49 %) were reclassified as normal risk after training. Following training, pCAD index changes were inversely correlated (p < 1.4 × 10−04) with changes in HDL-C, HDL size, and LDL size.
Conclusions
A higher pCAD index was associated with a worse cardiometabolic profile at baseline but improved with regular exercise. The results from this study highlight the potential role of HDL apolipoproteins as therapeutic targets for lifestyle interventions, particularly in high-risk individuals.
Sebastian Miranda-Maravi, Charles S. Schwartz, Prasun K Dev, Jacob L. Barber, Riley J Reasons, Ryan W. Pearce, Michael J. McPhaul, Robert E. Gerszten, Anand Rohatgi, Claude Bouchard, Timothy S. Collier, Mark A. Sarzynski
Treva Rice, Jean–Pierre Després, Louis Pérusse, Yuling Hong, Michael A. Province, Jean Bergeron, Jacques Gagnon, Arthur S. Leon, James S. Skinner, Jack H. Wilmore, Claude Bouchard, D. C. Rao
William G. Hoffmann, Yan Chen, Charles S. Schwartz, Jacob L. Barber, Prasun K Dev, Riley J Reasons, Sebastian Miranda-Maravi, Bridget Armstrong, Robert E. Gerszten, Günther Silbernagel, Robert J. Konrad, Claude Bouchard, Mark A. Sarzynski
Discussion(0)
No comments yet. Be the first to comment.